Uveal melanoma in 2026: what do we know and what’s ahead of us?

Join Dr. Carol Shields for a compelling seminar on the evolving landscape of uveal melanoma. From identifying high-risk choroidal nevi to understanding the genetic underpinnings of this rare ocular cancer, Dr. Shields offers a comprehensive overview of current diagnostics and treatments. She’ll share insights into minimizing radiation complications and explore cutting-edge developments in liquid biopsies and biomarkers. Discover how neoadjuvant trials are paving the way for metastasis prevention and why telehealth is becoming a vital tool in ocular oncology. Whether you're a clinician, researcher, or student, this session promises valuable perspectives on what we know—and what lies ahead.

Teams link to join the seminar: https://teams.microsoft.com/l/meetup-join/19%3ameeting_NWM3NTM2YjUtYzA0ZS00OTlmLWJkY2MtYjk3YmViMjlmYzQz%40thread.v2/0?context=%7b%22Tid%22%3a%22183ad437-6002-48ad-8886-c5885ce9be1a%22%2c%22Oid%22%3a%221ed1e97e-4bdf-4145-b23a-9858c31bd9e7%22%7d